Thank you, Mr. Chair.
In the health products and food branch, there is a bit of an ebb and flow. There are some amounts that are decreasing. Certainly one of the amounts that are increasing is an additional $6.1 million for strengthening the safety of drugs, medical devices, and other therapeutic products. That would be the first point I'd make.
The second point I'd make is that we're in the process now, as I think the committee is aware, of a consultation on a blueprint for the renewal of our regulatory systems. As that consultation goes forward, we will examine the resource needs. We'll look first internally to reallocation, but if that can't meet our needs, the case would be made for additional resources at the appropriate time.